RecallRadar

FDA Drug recall D-0579-2024

Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle, Rx Only, Manufactured for: Trigen Laboratories, LLC,…

On 2024-07-10 the FDA classified a Class II recall of Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle, Rx Only, Manufactured for: Trigen Laboratories, LLC,… by Trigen Laboratories, citing failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0579-2024
ClassificationClass II
Statusterminated
Initiated2024-06-17
Published2024-07-10
Last updated2026-09-13 11:52 UTC
CompanyTrigen Laboratories
DistributionUS

Product

Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle, Rx Only, Manufactured for: Trigen Laboratories, LLC, Alpharetta, GA 30005, NDC 13811-708-10

Reason

Failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications.

Identifiers

ndc13811-709-10
ndc13811-706-10
ndc13811-707-10
ndc13811-708-10
ndc13811-710-10
ndc13811-710-30
code_infoLot 230159M, Exp Date 2/28/2026

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0579-2024%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.